News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
MAST ERLE T
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/21/2022 |
4
| MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Sold 15,000 shares
@ $26.0864, valued at
$391.3k
Exercised 6,250 options to buy
@ $15.04, valued at
$94k
Exercised 4,375 options to buy
@ $14.88, valued at
$65.1k
Exercised 4,375 options to buy
@ $12, valued at
$52.5k
|
|
05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/28/2019 |
4
| MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Granted 13,000 options to buy
@ $39.02, valued at
$507.3k
|
|
11/26/2018 |
4
| MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Sold 1,468 shares
@ $42.0792, valued at
$61.8k
|
|
10/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2018 |
4
| MAST ERLE T (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns:
| Granted 10,000 options to buy
@ $15.08, valued at
$150.8k
|
|
05/24/2018 |
4
| MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Granted 15,000 options to buy
@ $41.68, valued at
$625.2k
|
|
08/01/2017 |
4
| MAST ERLE T (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns:
| Bought 6,700 shares
@ $15, valued at
$100.5k
|
|
07/26/2017 |
3
| MAST ERLE T (Director) has filed a Form 3 on Sienna Biopharmaceuticals, Inc. |
05/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/03/2015 |
4
| MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns:
| Sold 89 shares
@ $98.82, valued at
$8.8k
Sold 111 shares
@ $100.8027, valued at
$11.2k
Sold 100 shares
@ $102.67, valued at
$10.3k
Sold 500 shares
@ $104.284, valued at
$52.1k
Sold 400 shares
@ $105.095, valued at
$42k
Sold 1,000 shares
@ $106.3302, valued at
$106.3k
Sold 700 shares
@ $107.2886, valued at
$75.1k
Sold 100 shares
@ $108.16, valued at
$10.8k
|
|
10/02/2015 |
4
| MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns:
| Sold 900 shares
@ $89.4, valued at
$80.5k
Sold 1,580 shares
@ $90.28, valued at
$142.6k
Sold 420 shares
@ $91.3, valued at
$38.3k
Sold 100 shares
@ $92.09, valued at
$9.2k
|
|
09/03/2015 |
4
| MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns:
| Sold 200 shares
@ $76.39, valued at
$15.3k
Sold 400 shares
@ $78.2325, valued at
$31.3k
Sold 1,000 shares
@ $79.394, valued at
$79.4k
Sold 1,300 shares
@ $80.3431, valued at
$104.4k
Sold 100 shares
@ $81.07, valued at
$8.1k
|
|
08/27/2015 |
4
| MAST ERLE T (Director) has filed a Form 4 on Receptos, Inc.
Txns:
| Unknown transaction of 300 shares
@ $0 Disposed/sold 7,400 shares
@ $0 Disposed/sold 18,800 options to buy
@ $18.77, valued at
$352.9k
Disposed/sold 9,400 options to buy
@ $27.44, valued at
$257.9k
|
|
08/05/2015 |
4
| MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns:
| Sold 1,190 shares
@ $85.23, valued at
$101.4k
Sold 1,310 shares
@ $86.33, valued at
$113.1k
Sold 500 shares
@ $86.81, valued at
$43.4k
|
|
07/02/2015 |
4
| MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns:
| Sold 2,000 shares
@ $85.19, valued at
$170.4k
Sold 900 shares
@ $86.56, valued at
$77.9k
Sold 100 shares
@ $88.01, valued at
$8.8k
|
|
06/19/2015 |
4
| MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Granted 72,000 options to buy
@ $1.6, valued at
$115.2k
|
|
06/03/2015 |
4
| MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns:
| Sold 200 shares
@ $86.04, valued at
$17.2k
Sold 900 shares
@ $87.635, valued at
$78.9k
Sold 1,000 shares
@ $88.903, valued at
$88.9k
Sold 500 shares
@ $89.988, valued at
$45k
Sold 400 shares
@ $90.873, valued at
$36.3k
|
|
06/01/2015 |
4
| MAST ERLE T (Director) has filed a Form 4 on Receptos, Inc.
Txns:
| Granted 7,400 shares
@ $0 |
|
05/05/2015 |
4
| MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns:
| Sold 879 shares
@ $81.001, valued at
$71.2k
Sold 1,800 shares
@ $81.982, valued at
$147.6k
Sold 221 shares
@ $82.46, valued at
$18.2k
Sold 100 shares
@ $83.55, valued at
$8.4k
|
|
04/03/2015 |
4
| MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns:
| Sold 1,260 shares
@ $70.515, valued at
$88.8k
Sold 1,540 shares
@ $71.571, valued at
$110.2k
Sold 100 shares
@ $72.65, valued at
$7.3k
Sold 100 shares
@ $74.31, valued at
$7.4k
|
|
03/17/2015 |
4
| MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Granted 7,500 shares
@ $1.31, valued at
$9.8k
|
|
03/11/2015 |
4
| MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns:
| Sold 8,400 shares
@ $78.7781, valued at
$661.7k
Sold 500 shares
@ $79.555, valued at
$39.8k
Sold 100 shares
@ $80.4, valued at
$8k
|
|
03/04/2015 |
4
| MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns:
| Granted 35,000 options to buy
@ $79.05, valued at
$2.8M
|
|
06/05/2014 |
4
| MAST ERLE T (Director) has filed a Form 4 on Receptos, Inc.
Txns:
| Granted 9,400 options to buy
@ $27.44, valued at
$257.9k
|
|
05/22/2014 |
4
| MAST ERLE T (Director) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Granted 50,000 options to buy
@ $1.94, valued at
$97k
|
|
03/18/2014 |
4
| MAST ERLE T (Director) has filed a Form 4 on Receptos, Inc.
Txns:
| Bought 200 shares
@ $50.225, valued at
$10k
Bought 100 shares
@ $51.552, valued at
$5.2k
|
|
01/14/2014 |
4
| MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns:
| Granted 70,000 options to buy
@ $73.98, valued at
$5.2M
|
|
12/12/2013 |
4
| MAST ERLE T (Executive VP and CFO) has filed a Form 4 on Clovis Oncology, Inc.
Txns:
| Sold 25,177 shares
@ $53.8106, valued at
$1.4M
Sold 700 shares
@ $54.57, valued at
$38.2k
Sold 24,023 shares
@ $51.6393, valued at
$1.2M
Sold 100 shares
@ $52.38, valued at
$5.2k
|
|
07/19/2013 |
4
| MAST ERLE T (Director) has filed a Form 4 on Receptos, Inc.
Txns:
| Granted 18,800 options to buy
@ $18.77, valued at
$352.9k
|
|
|
|
|